通过电子监测在患有非控制性喘的儿童中进行指导吸入 (IMAGINE研究):随机对照试验
Esther Sportel1, Kris Movig1, Bernard Thio2,3
1Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, The Netherlands.
JMIR pediatrics and parenting
|November 14, 2025
概括
与没有反相比,智能吸入器反没有改善儿科喘控制. 然而,这两组都显示出临床改善,这表明需要在喘管理中采取适应性干预措施.
科学领域:
- 儿科肺病学 儿科肺病学
- 数字健康数字健康
- 临床试验 临床试验
背景情况:
- 儿童喘在荷兰是一种常见的慢性疾病,控制的坚持和技术至关重要.
- 目前的医院访问对这些关键参数的洞察力有限.
- 智能吸入器为家庭监测和反提供了潜在的潜力,以改善喘管理.
研究的目的:
- 评估智能吸入器反是否通过增强治疗坚持和吸入技术来改善喘控制.
- 评估立即反对儿科喘患者临床结果的影响.
主要方法:
- IMAGINE研究是一项三期随机对照试验 (RCT).
- 阶段包括观察,随机反 (干预) 或仅记录 (控制) 和最终观察.
- 用肺功能测试和验证的问卷来测量喘控制.
主要成果:
- 在临床参数 (肺功能变异性,喘控制测试分数) 的改善在两组中都被观察到,但在两组之间没有显著差异.
- 在1秒内预测的强迫呼气量没有改善.
- 随着时间的推移,干预组和对照组之间没有显著的差异.
结论:
- 智能吸入器反本身并没有与标准护理相比产生更好的结果.
- 在两组中观察到的临床改善突显了智能吸入器技术的潜力.
- 未来的研究应该专注于适应性,个性化的智能吸入器干预措施,以加强患者参与和掌握喘管理.
相关概念视频
Inhaled Medications
717
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
717
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
COPD: Management Using Bronchodilators and Corticosteroids
709
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
709
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K


